Loading…
Acanthoma planoepitheliale hyperkeratoticum, lesions associated with BRAF inhibitor in metastatic melanoma
Saved in:
Published in: | Journal of the European Academy of Dermatology and Venereology 2018-02, Vol.32 (2), p.e83-e84 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c2920-d0fb995bcceca1797f13283a0da70be7a6b326abf2e4cc126dadc999a6c8ef3c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c2920-d0fb995bcceca1797f13283a0da70be7a6b326abf2e4cc126dadc999a6c8ef3c3 |
container_end_page | e84 |
container_issue | 2 |
container_start_page | e83 |
container_title | Journal of the European Academy of Dermatology and Venereology |
container_volume | 32 |
creator | Sokołowska‐Wojdyło, M. Olszewska, B. Sobjanek, M. Sławińska, M. Sosińska‐Mielcarek, K. Biernat, W. Nowicki, R. |
description | |
doi_str_mv | 10.1111/jdv.14540 |
format | article |
fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1111_jdv_14540</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JDV14540</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2920-d0fb995bcceca1797f13283a0da70be7a6b326abf2e4cc126dadc999a6c8ef3c3</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EoqWw4AeQt0iktZ2nl6WlPFQJCQHbaOJMFJe8FLtU_XtcAuyYzdzFmavRIeSSsyl3M9vkn1MehAE7ImMeRInns8Q_JmMmReRJGcoROTNmwxjjPExOyUgkSRiLWIzJZq6gsWVbA-0qaFrstC2x0lAhLfcd9h_Yg22tVtv6hlZodNsYCsa0SoPFnO4cT29f5iuqm1Jn2ra9S7RGC8aCu3PxUFzDOTkpoDJ48bMn5G1197p48NbP94-L-dpTQgrm5azI3M-ZUqiAxzIuuC8SH1gOMcswhijzRQRZITBQiosoh1xJKSFSCRa-8ifkeuhVfWtMj0Xa9bqGfp9ylh58pc5X-u3LsVcD222zGvM_8leQA2YDsNMV7v9vSp-W70PlF0vfeEo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Acanthoma planoepitheliale hyperkeratoticum, lesions associated with BRAF inhibitor in metastatic melanoma</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Sokołowska‐Wojdyło, M. ; Olszewska, B. ; Sobjanek, M. ; Sławińska, M. ; Sosińska‐Mielcarek, K. ; Biernat, W. ; Nowicki, R.</creator><creatorcontrib>Sokołowska‐Wojdyło, M. ; Olszewska, B. ; Sobjanek, M. ; Sławińska, M. ; Sosińska‐Mielcarek, K. ; Biernat, W. ; Nowicki, R.</creatorcontrib><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/jdv.14540</identifier><identifier>PMID: 28857272</identifier><language>eng</language><publisher>England</publisher><subject>Acanthoma - chemically induced ; Acanthoma - pathology ; Aged ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Female ; Humans ; Imidazoles - administration & dosage ; Imidazoles - adverse effects ; Melanoma - drug therapy ; Melanoma - secondary ; Oximes - administration & dosage ; Oximes - adverse effects ; Pyridones - administration & dosage ; Pyrimidinones - administration & dosage ; Skin Neoplasms - drug therapy ; Skin Neoplasms - pathology</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2018-02, Vol.32 (2), p.e83-e84</ispartof><rights>2017 European Academy of Dermatology and Venereology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2920-d0fb995bcceca1797f13283a0da70be7a6b326abf2e4cc126dadc999a6c8ef3c3</citedby><cites>FETCH-LOGICAL-c2920-d0fb995bcceca1797f13283a0da70be7a6b326abf2e4cc126dadc999a6c8ef3c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28857272$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sokołowska‐Wojdyło, M.</creatorcontrib><creatorcontrib>Olszewska, B.</creatorcontrib><creatorcontrib>Sobjanek, M.</creatorcontrib><creatorcontrib>Sławińska, M.</creatorcontrib><creatorcontrib>Sosińska‐Mielcarek, K.</creatorcontrib><creatorcontrib>Biernat, W.</creatorcontrib><creatorcontrib>Nowicki, R.</creatorcontrib><title>Acanthoma planoepitheliale hyperkeratoticum, lesions associated with BRAF inhibitor in metastatic melanoma</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><subject>Acanthoma - chemically induced</subject><subject>Acanthoma - pathology</subject><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Imidazoles - administration & dosage</subject><subject>Imidazoles - adverse effects</subject><subject>Melanoma - drug therapy</subject><subject>Melanoma - secondary</subject><subject>Oximes - administration & dosage</subject><subject>Oximes - adverse effects</subject><subject>Pyridones - administration & dosage</subject><subject>Pyrimidinones - administration & dosage</subject><subject>Skin Neoplasms - drug therapy</subject><subject>Skin Neoplasms - pathology</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kMtOwzAQRS0EoqWw4AeQt0iktZ2nl6WlPFQJCQHbaOJMFJe8FLtU_XtcAuyYzdzFmavRIeSSsyl3M9vkn1MehAE7ImMeRInns8Q_JmMmReRJGcoROTNmwxjjPExOyUgkSRiLWIzJZq6gsWVbA-0qaFrstC2x0lAhLfcd9h_Yg22tVtv6hlZodNsYCsa0SoPFnO4cT29f5iuqm1Jn2ra9S7RGC8aCu3PxUFzDOTkpoDJ48bMn5G1197p48NbP94-L-dpTQgrm5azI3M-ZUqiAxzIuuC8SH1gOMcswhijzRQRZITBQiosoh1xJKSFSCRa-8ifkeuhVfWtMj0Xa9bqGfp9ylh58pc5X-u3LsVcD222zGvM_8leQA2YDsNMV7v9vSp-W70PlF0vfeEo</recordid><startdate>201802</startdate><enddate>201802</enddate><creator>Sokołowska‐Wojdyło, M.</creator><creator>Olszewska, B.</creator><creator>Sobjanek, M.</creator><creator>Sławińska, M.</creator><creator>Sosińska‐Mielcarek, K.</creator><creator>Biernat, W.</creator><creator>Nowicki, R.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201802</creationdate><title>Acanthoma planoepitheliale hyperkeratoticum, lesions associated with BRAF inhibitor in metastatic melanoma</title><author>Sokołowska‐Wojdyło, M. ; Olszewska, B. ; Sobjanek, M. ; Sławińska, M. ; Sosińska‐Mielcarek, K. ; Biernat, W. ; Nowicki, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2920-d0fb995bcceca1797f13283a0da70be7a6b326abf2e4cc126dadc999a6c8ef3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acanthoma - chemically induced</topic><topic>Acanthoma - pathology</topic><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Imidazoles - administration & dosage</topic><topic>Imidazoles - adverse effects</topic><topic>Melanoma - drug therapy</topic><topic>Melanoma - secondary</topic><topic>Oximes - administration & dosage</topic><topic>Oximes - adverse effects</topic><topic>Pyridones - administration & dosage</topic><topic>Pyrimidinones - administration & dosage</topic><topic>Skin Neoplasms - drug therapy</topic><topic>Skin Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sokołowska‐Wojdyło, M.</creatorcontrib><creatorcontrib>Olszewska, B.</creatorcontrib><creatorcontrib>Sobjanek, M.</creatorcontrib><creatorcontrib>Sławińska, M.</creatorcontrib><creatorcontrib>Sosińska‐Mielcarek, K.</creatorcontrib><creatorcontrib>Biernat, W.</creatorcontrib><creatorcontrib>Nowicki, R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sokołowska‐Wojdyło, M.</au><au>Olszewska, B.</au><au>Sobjanek, M.</au><au>Sławińska, M.</au><au>Sosińska‐Mielcarek, K.</au><au>Biernat, W.</au><au>Nowicki, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acanthoma planoepitheliale hyperkeratoticum, lesions associated with BRAF inhibitor in metastatic melanoma</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2018-02</date><risdate>2018</risdate><volume>32</volume><issue>2</issue><spage>e83</spage><epage>e84</epage><pages>e83-e84</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><cop>England</cop><pmid>28857272</pmid><doi>10.1111/jdv.14540</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0926-9959 |
ispartof | Journal of the European Academy of Dermatology and Venereology, 2018-02, Vol.32 (2), p.e83-e84 |
issn | 0926-9959 1468-3083 |
language | eng |
recordid | cdi_crossref_primary_10_1111_jdv_14540 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Acanthoma - chemically induced Acanthoma - pathology Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Female Humans Imidazoles - administration & dosage Imidazoles - adverse effects Melanoma - drug therapy Melanoma - secondary Oximes - administration & dosage Oximes - adverse effects Pyridones - administration & dosage Pyrimidinones - administration & dosage Skin Neoplasms - drug therapy Skin Neoplasms - pathology |
title | Acanthoma planoepitheliale hyperkeratoticum, lesions associated with BRAF inhibitor in metastatic melanoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T07%3A04%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acanthoma%20planoepitheliale%20hyperkeratoticum,%20lesions%20associated%20with%20BRAF%20inhibitor%20in%20metastatic%20melanoma&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Soko%C5%82owska%E2%80%90Wojdy%C5%82o,%20M.&rft.date=2018-02&rft.volume=32&rft.issue=2&rft.spage=e83&rft.epage=e84&rft.pages=e83-e84&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/jdv.14540&rft_dat=%3Cwiley_cross%3EJDV14540%3C/wiley_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2920-d0fb995bcceca1797f13283a0da70be7a6b326abf2e4cc126dadc999a6c8ef3c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/28857272&rfr_iscdi=true |